Skip to main content
SpringerLink
Log in

Isolated Limb Perfusion With Tumor Necrosis Factor and Melphalan Prevents Amputation in Patients With Multiple Sarcomas in Arm or Leg

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Treatment for extremity soft tissue sarcoma (STS) has shifted in recent years from amputation to local wide excision combined with irradiation. For multiple sarcomas, this limb-sparing approach is often not possible. To avoid amputations, isolated limb perfusion (ILP) with tumor necrosis factor and melphalan is an attractive treatment option for patients with multiple extremity sarcomas.

Methods

We investigated a prospective database at a tertiary referral institute. From July 1991 to July 2003, out of 217 ILPs, 64 ILPs were performed for either multifocal primary sarcomas or multiple sarcoma recurrences in 53 patients. All ILPs were performed under mild hyperthermic conditions by using 1 to 4 mg of tumor necrosis factor and 10 to 13 mg/L of limb volume for leg and arm perfusions, respectively.

Results

The overall response was 88%, with 42% complete response, 45% partial response, 11% no change, and 2% progressive disease. This response rate is significantly better than our experience in 153 locally advanced single-STS cases (88% vs. 69%). The toxicity of the procedure was mild to moderate in almost all cases; no treatment-related amputation had to be performed. The time to local recurrence was 29 months and differed significantly between multiple primary and multiple recurrent STS. The 5-year survival rate was 39%. Limb salvage was achieved in 45 (82%) of 55 treated limbs.

Conclusions

In a group of patients who are uniformly candidates for amputation, ILP can achieve limb salvage in approximately four out of five patients. Because this treatment option provides excellent local control, it should be considered before an amputation is planned.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. SH Landis T Murray S Bolden PA Wingo (1999) ArticleTitleCancer statistics, 1999 CA Cancer J Clin 49 8–31 Occurrence Handle1:STN:280:DyaK1M3hs1OrsA%3D%3D Occurrence Handle10200775

    CAS  PubMed  Google Scholar 

  2. AM Eggermont H Schraffordt Koops D Lienard et al. (1996) ArticleTitleIsolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial J Clin Oncol 14 2653–65 Occurrence Handle1:CAS:528:DyaK28XmsFCgtr0%3D Occurrence Handle8874324

    CAS  PubMed  Google Scholar 

  3. AM Eggermont H Schraffordt Koops JM Klausner et al. (1996) ArticleTitleIsolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience Ann Surg 224 756–64 Occurrence Handle10.1097/00000658-199612000-00011 Occurrence Handle1:STN:280:DyaK2s7it12rsw%3D%3D Occurrence Handle8968230

    Article  CAS  PubMed  Google Scholar 

  4. M Gutman M Inbar D Lev-Shlush et al. (1997) ArticleTitleHigh dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation Cancer 79 1129–37 Occurrence Handle1:CAS:528:DyaK2sXit1artro%3D Occurrence Handle9070490

    CAS  PubMed  Google Scholar 

  5. CR Rossi M Foletto F Di Filippo et al. (1999) ArticleTitleSoft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusion Cancer 86 1742–9 Occurrence Handle10.1002/(SICI)1097-0142(19991101)86:9<1742::AID-CNCR16>3.0.CO;2-G Occurrence Handle1:STN:280:DC%2BD3c%2Fhs1ejsA%3D%3D Occurrence Handle10547547

    Article  CAS  PubMed  Google Scholar 

  6. FJ Lejeune N Pujol D Lienard et al. (2000) ArticleTitleLimb salvage by neoadjuvant isolated perfusion with TNF alpha and melphalan for non-resectable soft tissue sarcoma of the extremities Eur J Surg Oncol 26 669–78 Occurrence Handle1:STN:280:DC%2BD3M%2Fms1Squw%3D%3D Occurrence Handle11078614

    CAS  PubMed  Google Scholar 

  7. P Hohenberger C Kettelhack A Hermann PM Schlag (2001) ArticleTitleFunctional outcome after preoperative isolated limb perfusion with rhTNF alpha/melphalan for high-grade extremity sarcoma Eur J Cancer 37 S34–5 Occurrence Handle10.1016/S0959-8049(01)80607-9

    Article  Google Scholar 

  8. EM Noorda BC Vrouenraets OE Nieweg et al. (2003) ArticleTitleIsolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities Cancer 98 1483–90 Occurrence Handle10.1002/cncr.11648 Occurrence Handle1:CAS:528:DC%2BD3sXot1Wju7c%3D Occurrence Handle14508836

    Article  CAS  PubMed  Google Scholar 

  9. AM Eggermont JH de Wilt TL ten Hagen (2003) ArticleTitleCurrent uses of isolated limb perfusion in the clinic and a model system for new strategies Lancet Oncol 4 429–37 Occurrence Handle10.1016/S1470-2045(03)01141-0 Occurrence Handle12850194

    Article  PubMed  Google Scholar 

  10. W Ruka LJ Emrich DL Driscoll CP Karakousis (1989) ArticleTitleClinical factors and treatment parameters affecting prognosis in adult high-grade soft tissue sarcomas: a retrospective review of 267 cases Eur J Surg Oncol 15 411–23 Occurrence Handle1:STN:280:DyaK3c%2Fgs1Sgsw%3D%3D Occurrence Handle2792392

    CAS  PubMed  Google Scholar 

  11. SL Blair JJ Lewis D Leung et al. (1998) ArticleTitleMultifocal extremity sarcoma: an uncommon and controversial entity Ann Surg Oncol 5 37–40 Occurrence Handle1:STN:280:DyaK1c7osFeqtg%3D%3D Occurrence Handle9524706

    CAS  PubMed  Google Scholar 

  12. DA Potter T Kinsella E Glatstein et al. (1986) ArticleTitleHigh-grade soft tissue sarcomas of the extremities Cancer 58 190–205 Occurrence Handle1:STN:280:DyaL283hslKluw%3D%3D Occurrence Handle3518911

    CAS  PubMed  Google Scholar 

  13. WC Williard SI Hajdu ES Casper MF Brennan (1992) ArticleTitleComparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity Ann Surg 215 269–75 Occurrence Handle1:STN:280:DyaK387otFantA%3D%3D Occurrence Handle1543400 Occurrence Handle10.1097/00000658-199203000-00012

    Article  CAS  PubMed  Google Scholar 

  14. PW Pisters DH Leung J Woodruff et al. (1996) ArticleTitleAnalysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities J Clin Oncol 14 1679–89 Occurrence Handle1:STN:280:DyaK283gvVynuw%3D%3D Occurrence Handle8622088

    CAS  PubMed  Google Scholar 

  15. M Trojani G Contesso JM Coindre et al. (1984) ArticleTitleSoft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system Int J Cancer 33 37–42 Occurrence Handle1:STN:280:DyaL2c7htVKhuw%3D%3D Occurrence Handle6693192

    CAS  PubMed  Google Scholar 

  16. CS Rijswijk Particlevan MJ Geirnaerdt PC Hogendoorn et al. (2003) ArticleTitleDynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results Eur Radiol 13 1849–58 Occurrence Handle10.1007/s00330-002-1785-4 Occurrence Handle12942285

    Article  PubMed  Google Scholar 

  17. D Vanel S Bonvalot JM Guinebretiere et al. (2004) ArticleTitleMR imaging in the evaluation of isolated limb perfusion: a prospective study of 18 cases Skeletal Radiol 33 150–6 Occurrence Handle10.1007/s00256-003-0726-x Occurrence Handle14747961

    Article  PubMed  Google Scholar 

  18. J Wieberdink C Benckhuysen RP Braat et al. (1982) ArticleTitleDosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions Eur J Cancer Clin Oncol 18 905–10 Occurrence Handle1:STN:280:DyaL3s7jtFOksQ%3D%3D Occurrence Handle6891640

    CAS  PubMed  Google Scholar 

  19. ET Krementz RD Carter CM Sutherland I Hutton (1977) ArticleTitleChemotherapy of sarcomas of the limbs by regional perfusion Ann Surg 185 555–64 Occurrence Handle1:STN:280:DyaE2s7otVGltg%3D%3D Occurrence Handle266397

    CAS  PubMed  Google Scholar 

  20. HJ Hoekstra H Schraffordt Koops WM Molenaar J Oldhoff (1987) ArticleTitleResults of isolated regional perfusion in the treatment of malignant soft tissue tumors of the extremities Cancer 60 1703–7 Occurrence Handle1:STN:280:DyaL1c%2FgtF2isA%3D%3D Occurrence Handle2820562

    CAS  PubMed  Google Scholar 

  21. JM Klaase BB Kroon C Benckhuijsen et al. (1989) ArticleTitleResults of regional isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities Cancer 64 616–21 Occurrence Handle1:STN:280:DyaL1MzgtlOitw%3D%3D Occurrence Handle2743257

    CAS  PubMed  Google Scholar 

  22. BW Feig MI Ross KK Hunt (2004) ArticleTitleA prospective evaluation of isolated limb perfusion with doxorubicin in patients with unresectable extremity sarcomas (abstract 98) Ann Surg Oncol 11 IssueID(Suppl) S80

    Google Scholar 

  23. D Lev-Chelouche S Abu-Abeid Y Kollander et al. (1999) ArticleTitleMultifocal soft tissue sarcoma: limb salvage following hyperthermic isolated limb perfusion with high-dose tumor necrosis factor and melphalan J Surg Oncol 70 185–9 Occurrence Handle10.1002/(SICI)1096-9098(199903)70:3<185::AID-JSO8>3.0.CO;2-# Occurrence Handle1:STN:280:DyaK1M3gtVCksQ%3D%3D Occurrence Handle10102350

    Article  CAS  PubMed  Google Scholar 

  24. DJ Grünhagen F Brunstein WJ Graveland et al. (2004) ArticleTitleOne hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases Ann Surg 240 939–47 Occurrence Handle10.1097/01.sla.0000146147.89667.ed Occurrence Handle15570199

    Article  PubMed  Google Scholar 

  25. D Lev-Chelouche S Abu-Abeid O Merimsky et al. (1999) ArticleTitleIsolated limb perfusion with high-dose tumor necrosis factor alpha and melphalan for Kaposi sarcoma Arch Surg 134 177–80 Occurrence Handle10.1001/archsurg.134.2.177 Occurrence Handle1:CAS:528:DyaK1MXhsFSgs7Y%3D Occurrence Handle10025459

    Article  CAS  PubMed  Google Scholar 

  26. TE Lans JH de Wilt AN van Geel AM Eggermont (2002) ArticleTitleIsolated limb perfusion with tumor necrosis factor and melphalan for nonresectable Stewart-Treves lymphangiosarcoma Ann Surg Oncol 9 1004–9 Occurrence Handle10.1245/ASO.2002.03.048 Occurrence Handle1:STN:280:DC%2BD38jgt1Grsg%3D%3D Occurrence Handle12464594

    Article  CAS  PubMed  Google Scholar 

  27. JJ Lewis PJ Boland DH Leung et al. (1999) ArticleTitleThe enigma of desmoid tumors Ann Surg 229 866–72 Occurrence Handle10.1097/00000658-199906000-00014 Occurrence Handle1:STN:280:DyaK1M3ptVGluw%3D%3D Occurrence Handle10363901

    Article  CAS  PubMed  Google Scholar 

  28. J Weitz CR Antonescu MF Brennan (2003) ArticleTitleLocalized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time J Clin Oncol 21 2719–25 Occurrence Handle10.1200/JCO.2003.02.026 Occurrence Handle12860950

    Article  PubMed  Google Scholar 

  29. Lans TA, Grünhagen DJ, de Wilt JHW, et al. Isolated limb perfusions with TNF and melphalan for locally recurrent soft tissue sarcoma in previously irradiated limbs. Ann Surg Oncol 2005;12: in press.

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, 301 Groene Hilledijk, 3075 EA, Rotterdam, The Netherlands

    Dirk J. Grünhagen MD, Flavia Brunstein MD, Albertus N. van Geel MD, PhD, Johannes H. W. de Wilt MD, PhD & Alexander M. M. Eggermont MD, PhD

  2. Department of Statistics, Erasmus MC-Daniel den Hoed Cancer Center, 301 Groene Hilledijk, 3075 EA, Rotterdam, The Netherlands

    Wilfried J. Graveland MSc

Authors
  1. Dirk J. Grünhagen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Flavia Brunstein MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wilfried J. Graveland MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Albertus N. van Geel MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Johannes H. W. de Wilt MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alexander M. M. Eggermont MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander M. M. Eggermont MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grünhagen, D.J., Brunstein, F., Graveland, W.J. et al. Isolated Limb Perfusion With Tumor Necrosis Factor and Melphalan Prevents Amputation in Patients With Multiple Sarcomas in Arm or Leg. Ann Surg Oncol 12, 473–479 (2005). https://doi.org/10.1245/ASO.2005.03.059

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2005.03.059

Keywords

Search

Navigation